Skip to main content
. 2022 Mar 15;14:17588359221083956. doi: 10.1177/17588359221083956

Figure 1.

Figure 1.

(a) Amcenestrant, an oral SERD, antagonizes and degrades the ER, resulting in inhibition of the ER signaling pathway and (b) amcenestrant structure.

E, estrogen; ER, estrogen receptor; SERD, selective estrogen receptor degrader; SERM, selective estrogen receptor modulator.